Search company, investor...
Sygen Pharmaceuticals company logo

Sygen Pharmaceuticals

sygenpharma.com

Stage

Corporate Minority | Alive

About Sygen Pharmaceuticals

Sygen Pharmaceuticals produces and distributes pharmaceutical products in Nigeria.

Headquarters Location

Nigeria

Missing: Sygen Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sygen Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Sygen Pharmaceuticals News

Africa Deal Roundup: 15 deal, fundraising and exit announcements in January

Feb 1, 2021

XSML made a follow-on investment in Ecopharm, a pharmacy chain in Uganda. This article is published in association with Africa Private Equity News, a one-stop source for industry-related information. Stay up to date by downloading the free Africa Private Equity News app:  Android | iOS | www.africaprivateequitynews.com . *** A selection of African private equity deal, fundraising and exit announcements that came across our desk in January 2021. Deals Eos Capital, the Namibian private equity firm, acquired a minority stake in Erongo Medical Group (EMG). EMG is a substantial player in the Namibian healthcare industry with Welwitschia Hospital in Walvis Bay as its flagship. EMG’s other subsidiaries, at varying ownership stakes, include Erongo Radiology, Ongwediva Medipark and Medixx Occupational Health Services. Àrgentil Capital Management has made an equity investment in Sygen Pharmaceuticals. The investment was structured via the sponsor’s investment vehicle Consumer Growth Partners along with other co-investors. Sygen is an indigenous pharmaceutical company incorporated in 2019 to acquire the key operating assets of Nigerian German Chemicals. XSML, the fund manager active in Central and East Africa, signed its fourth investment in Ecopharm, the pharmacy chain in Uganda. Daystar Power, a provider of hybrid solar power solutions to businesses in West Africa, announced a series B investment of $38 million. The round was led by the Investment Fund for Developing Countries (IFU), the Danish development finance institution. IFU is joined by new investors STOA, a French impact infrastructure fund; Proparco, the French DFI; and Morgan Stanley Investment Management. Taking into account the previous round by Verod Capital and Persistent Energy, Daystar Power has received equity investments totalling $48 million. uLesson, the African learning technology platform, has closed a $7.5 million series A round led by Owl Ventures, with inclusion from existing investors, TLcom Capital and Founder Collective and participation from new investor LocalGlobe. The Agri-Business Capital (ABC) Fund has provided a loan of €800,000 to Enterprise Cooperative Kimbe (Ecookim) ahead of the 2020/21 cocoa production season. Ecookim is a union of 29 cooperatives located in rural communities across 12 different provinces in Côte d’Ivoire. The ABC Fund is managed by Bamboo Capital Partners in partnership with Injaro as investment advisors and with technical assistance led by Agriterra. Funds advised by Kasada Capital Management announced the first transaction made through the debut fund, Kasada Hospitality Fund LP, acquiring a portfolio of sub-Saharan African hotels from AccorInvest. The landmark deal is one of the largest cross-border hospitality M&A transactions in Africa and will see Kasada take control of eight fully operational hotels across three countries – Côte d’Ivoire, Senegal and Cameroon – comprising 1,602 hotel rooms focussed on servicing intra-regional business travel in Africa. Pula, an African insurtech service provider startup that specialises in digital and agricultural insurance to derisk millions of smallholder farmers across Africa, has closed a $6 million series A fundraise. The investment was led by TLcom Capital, with the participation of Women’s World Banking. AXA IM Alts, a global alternatives investment firm, through the AXA Impact Fund Climate and Biodiversity, along with Mani Kapital and Kepple Ventures, have invested in Sanergy, an organics recycling company transforming how cities in the developing world manage waste by upcycling it into valuable agricultural inputs – insect-based protein for animal feed, organic fertiliser, and biomass fuel. With AXA IM Alts’s support, Sanergy would be well-positioned to scale its operations in Kenya and across the region. Fundraising Dutch development financier FMO has approved a $10 million investment in Ascent Rift Valley Fund II (ARVF II), managed by Ascent Capital Africa. ARVF II aims to invest in and develop regional SMEs in East Africa. The fund has a target size of $120 million. The Facility for Energy Inclusion (FEI) has received a further $24 million subscription by KfW. With this additional allocation, KfW on behalf of the German Ministry for Economic Cooperation and Development (BMZ) has now committed a total of $52 million to FEI, bringing FEI’s total equity base to about $145 million and the total potential fund size to just under $400 million. FEI is designed to support small-scale independent power producers. The African Development Bank is the anchor sponsor of FEI. SPE Capital Partners announced the final close of SPE AIF I, an Africa-focused private equity fund. SPE AIF I was oversubscribed and closed at $258 million, well above its initial hard cap of $200 million. SPE AIF I was launched in 2019 to invest in companies across Africa, with a particular focus on North Africa. The fund strategy includes majority transactions in companies with growth potential, operating in sectors such as industrial goods, services, healthcare and education. The European Union (EU) has committed €19.7 million to Climate Investor Two (CI2), the second facility under the management of Climate Fund Managers. This investment in CI2 is channelled through the EU’s partner bank – the Dutch Development Bank (FMO). The focus of CI2 is to form a direct response to both the threat that climate change poses to water security, and the threat that improper wastewater management poses to ecosystems. Exits Actis, a private capital investment firm, has successfully exited its stake in C&I Leasing Plc, through a trade sale to Peace Mass Transit Limited, a leading transport company in Nigeria. Nigeria-based C&I Leasing Plc is a diversified leasing and business service company providing support services to various indigenous and multinational organisations in West Africa along three lines: fleet management, personnel outsourcing and marine services. Mediterrania Capital Partners, a private equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and sub-Saharan countries, has announced the sale of its remaining stake in Cash Plus – the largest independent money transfer company in Morocco – to a group of Moroccan family offices. In July 2014, Mediterrania Capital Partners entered Cash Plus’s equity by acquiring a 49% stake. Related articles

Sygen Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sygen Pharmaceuticals Rank

Sygen Pharmaceuticals Frequently Asked Questions (FAQ)

  • What is Sygen Pharmaceuticals's latest funding round?

    Sygen Pharmaceuticals's latest funding round is Corporate Minority.

  • Who are the investors of Sygen Pharmaceuticals?

    Investors of Sygen Pharmaceuticals include Argentil Capital Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.